Clinical Trial Update: Autologous CAR-T Cells Targeting B7-H3 in PDAC [Phase 1]

View source ↗

Summary

An ongoing Phase 1 clinical trial is evaluating autologous CAR-T cells targeting B7-H3 for pancreatic cancer, and recruitment is currently open.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Autologous CAR-T Cells Targeting B7-H3 in PDAC

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Pancreas Cancer, Relapse | Phase 1 | Status: RECRUITING